The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R*,4R*,6S*)-2-(4-Bromophenyl)tetrahydro-4-phenyl-6-(thiocyanatomethyl)-2H-pyran-4-ol ID: ALA1094096
PubChem CID: 46220727
Max Phase: Preclinical
Molecular Formula: C19H18BrNO2S
Molecular Weight: 404.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#CSC[C@@H]1C[C@@](O)(c2ccccc2)C[C@H](c2ccc(Br)cc2)O1
Standard InChI: InChI=1S/C19H18BrNO2S/c20-16-8-6-14(7-9-16)18-11-19(22,15-4-2-1-3-5-15)10-17(23-18)12-24-13-21/h1-9,17-18,22H,10-12H2/t17-,18+,19-/m0/s1
Standard InChI Key: PBQRRRNLLBVHCJ-OTWHNJEPSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-1.7125 -15.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7125 -16.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0005 -16.7708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2885 -16.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2885 -15.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0005 -15.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4208 -14.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0074 -13.6822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4270 -12.9661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2588 -12.9713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6690 -13.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2470 -14.4119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5958 -14.4042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4254 -16.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4254 -16.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1405 -16.3646 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.8543 -16.7781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5667 -17.1875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1389 -16.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8513 -16.7776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8496 -17.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1296 -18.0131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4201 -17.5974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5625 -18.0182 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
11 12 2 0
12 7 1 0
5 6 1 0
6 13 1 1
2 14 1 1
6 7 1 0
4 15 1 1
1 2 1 0
15 16 1 0
7 8 2 0
16 17 1 0
1 6 1 0
17 18 3 0
8 9 1 0
14 19 2 0
2 3 1 0
19 20 1 0
9 10 2 0
20 21 2 0
3 4 1 0
21 22 1 0
10 11 1 0
22 23 2 0
23 14 1 0
4 5 1 0
21 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.33Molecular Weight (Monoisotopic): 403.0242AlogP: 4.77#Rotatable Bonds: 4Polar Surface Area: 53.25Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.90CX Basic pKa: ┄CX LogP: 4.17CX LogD: 4.17Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: 0.24
References 1. Singh P, Bhardwaj A.. (2010) Mono-, di-, and triaryl substituted tetrahydropyrans as cyclooxygenase-2 and tumor growth inhibitors. Synthesis and biological evaluation., 53 (9): [PMID:20387815 ] [10.1021/jm1001327 ]